Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1987-08-10
1991-04-16
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
514917, A61K 3332
Patent
active
050081195
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
This invention relates to a pharmaceutical agent acting on the protection mechanisms in human or animal bodies and, more particularly, to a pharmaceutical agent having activity of protecting living bodies from non-specific oxidative invasions thereof.
BACKGROUND OF THE INVENTION
Living bodies are exposed to a variety of environmental impacts. Such impacts are almost unlimited in number, including not only physical stimulations such as unceasingly arriving cosmic rays, radiations from the ground surface or buildings, ultraviolet rays in the sunlight and changes in ambient temperature but also chemical stimulations due to absorption of trace polutants in the air or foreign substances in foods and biological invasions by invisible viruses, bacterial, fungi, etc. Each living body is endowed with a very sophisticated and potent protection mechanism and it is this protection mechanism that allow the living organism to survive while overcoming those variegated invasions.
Fundamentally, the mechanism of living body damage by oxidative invasions from the environment and the defense mechanism are common in many aspects irrespective of differences in environmental factors. Thus, it is known that radiation damages, oxidant damages, inflammations, immunization, aging, carcinogenesis and various enzymatic processes are associated with free radical formation or active oxygen. It is also known that when many drugs act in human bodies, their metabolic processes involve free radical formation as a part thereof. Free radical formation is generally a factor harmful to healthy tissues except for its usefulness in some cases, for example in the case of microbicidal action of leukocytes or activation of certain enzymes in which .O.sub.2.sup.- (superoxide radical) is physiologically involved. Living bodies have a nonspecific defense system against such free radical formation. More in detail, when a living body is exposed to a radiation or oxidant or to an action of a drug, such agent not only directly damages substances of biological importance, such as DNA, but also reacts with O.sub.2 in the air to produce .O.sub.2.sup.- or reacts with water (H.sub.2 O) in a tissue to form strongly reactive radicals such as .OH (hydroxy radical). The .O.sub.2.sup.- radical is partly eliminated as a result of conversion to H.sub.2 O.sub.2 by SOD (superoxide dismutase) occurring in tissues. While catalase converts H.sub.2 O.sub.2 to water and oxygen, H.sub.2 O.sub.2 also reacts with .O.sub.2.sup.- to form .OH, which has very high reactivity and attacks a variety of living-body substances. In particular, these reactions, via formation of lipid radicals, lead to peroxidation of unsaturated fatty acid components of phospholipids which are constituents of biomembranes. It is vitamin E that plays a definite role in blocking chain reactions involving those free radicals that are formed from such membrane lipids. When subjected to lipid peroxidation, biomembranes undergo polymerization and their functions are thereby disturbed. This results in temporary inhibition of different biochemical reactions or in abnormalities in the adrenocortical hormone activities. Damages of biomembranes due to the formation of lipid peroxides are prevented by the peroxide eliminating action of the glutathione (GSH)-peroxidase system (GP system).
As mentioned above, living organisms are subjected to various oxidative invasions from outside and inside. At the same time, however, the defense mechanism functions in them through the action of vitamin E and the radical- or peroxide-eliminating action of the above-mentioned SOD or GP system, among others. In case this defense mechanism fails to function satisfactorily, long-term effects of said invasions will result in such general phenomena as ischemic disorders of the brain or heart, damages of the lung and aging of cells. Such various radicals may damage DNA molecules directly and this may lead to carcinogenesis. Furthermore, a number of chemical carcinogens and intermediate metabolites include free radicals
REFERENCES:
patent: 1962371 (1934-06-01), Torigian
patent: 2034783 (1936-03-01), Torigian
patent: 3887704 (1975-06-01), Lichtenstein
patent: 4349536 (1982-06-01), Hausler
Remington's Pharmaceutical Sciences 15th ed. (1975), pp. 968-970.
Kagaku et al., Function and Sod-Like Activity of Metallothionein, Metallothionein and SOD Yakassei, vol. 22, No. 2, Feb. 1984 (Tokyo).
Webb, M. et al., Functions of Metallothionein, Biochem. Pharmacol., vol. 31, No. 2, pp. 137-142 (1982).
Karin, M., Metallothioneins: Proteins in Search of Function, Cell, vol. 41, pp. 9-10 (May, 1985).
Fuwa, K., Elements for Inducing and Not Inducing Metallothionein Biosynthesis, Living Organisms and Heavy Metal, pp. 190-191 (1981).
Ishida, N., Immunopotentiating Activities of OK-432, Excerpta Medica, (1986) (Japanese and English).
Tsukagoshi, S., Host-Mediated Antitumor Activity of Polysaccharides, With Special Reference to the Effect of PS-K. A Protein-Bound Polysaccaride Isolated From Basidiomycetes, Cancer and Chemotherapy, vol. 1, No. 2, pp. 251-257 (1974).
Tsukagoshi, S., Basic Studies of Immunochemical Therapy Utilizing Polysaccharides, Advances in Medicine, vol. 91, No. 9, pp. 505-510 (Nov., 1974).
Onosaka, S. et al., A Simplified Procedure for Determination of Metallothionein in Animal Tissues, Eisei Kagaku, vol. 24, pp. 128-131 (1978).
Ohara, H., et al., Variations of Cellular Sulfhydryl Content During Cell Cycle of HeLa Cells and Its Correlation to Cyclic Change of X-Ray Sensitivity, Exptl. Cell. Res., vol. 58, pp. 182-185 (1970).
Modig, H. G. et al., Release of Thiols From Cellular Mixed Disulphides and Its Possible Role in Radiation Protection, Int. J. Radiat. Biol., vol. 22, No. 3, pp. 257-268 (1971).
Boyd, S. C. et al., High Concentrations of Glutathione in Glandular Stomach: Possible Implications for Carcinogenesis, Science, vol. 205, pp. 1010-1012 (1979).
Onosaka, S. et al., Concentration of Metallothionein in Malignant and Non-Malignant Tissues in Human Liver, Eisei Kagaku, vol. 30, pp. 173-176 (1984).
Friedman Stanley J.
Henley III Raymond J.
LandOfFree
Method of using manganese to protect an animal from radiation da does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using manganese to protect an animal from radiation da, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using manganese to protect an animal from radiation da will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-420334